European Neuropsychopharmacology
March 1, 2014
Andrew C. Parrott, H. Sands, Lewis Jones et al.
35 citations
Repeated heavy use of Ecstasy/MDMA is associated with nearly 4-fold higher cortisol levels in hair compared to non-users. Hair samples from 101 participants (aged 21.75 years on average) showed that heavy users (5+ times in 3 months) had mean cortisol levels of 55.0 pg/mg, light users (1-4 times) had 19.4 pg/mg, and non-users had 13.8 pg/mg. The difference between heavy users and non-users was statistically significant. These elevated cortisol levels may help explain cognitive, psychiatric, and other problems seen in some abstinent users and support the bio-energetic stress model for MDMA.
Behavioural Pharmacology
July 11, 2014
A. C. Parrott, Catharine Montgomery, Mark Wetherell et al.
34 citations
Recreational use of MDMA (ecstasy) increases cortisol levels, a marker of stress, both immediately and over longer periods. In laboratory settings, acute use raises cortisol by 100-200%, while dance clubbers combining the drug with dancing experience an 800% increase. Abstinent users' three-month hair samples show cortisol levels 400% higher than controls. Chronic users exhibit heightened cortisol in stressful settings, deficits in complex cognitive tasks, and altered brain activation patterns suggesting increased mental effort. Mood deficits include more daily stress and higher depression in susceptible individuals. Changes in the hypothalamic-pituitary-adrenal (HPA) axis may explain these neuropsychobiological stress effects.
Psychoactives
March 25, 2024
Agnieszka D. Sekula, Prashanth Puspanathan, Luke A. Downey et al.
1 citation
A review of three interventions that produce altered states of consciousness—psychedelic-assisted psychotherapy, Transcendental Meditation, and hypnotherapy—finds that the first two are linked to significant reductions in substance misuse and improvements in emotional, cognitive, and social functioning, motivation, self-identity, and meaning. Hypnotherapy, despite wider acceptance, shows mixed and minimal results for substance misuse treatment. The review notes common phenomenological, psychological, and neurobiological features among the interventions, suggesting possible convergent mechanisms, but also highlights mixed findings and methodological issues. Key research gaps and promising future directions are outlined.